Indian Pharmacopoeia (IP) 2026 Becomes First Globally to Establish Exclusive Blood Standards

Exam-focused facts from the 26 June 2026 current affairs briefing.

Key facts

The Indian Pharmacopoeia (IP) 2026 is the first pharmacopoeia in the world to establish exclusive standards for blood and blood components.
The Indian Pharmacopoeia Commission (IPC) organised a national conference at its Ghaziabad campus to facilitate the awareness and implementation of these monographs.
The newly incorporated standards aim to strengthen quality assurance, patient safety, and regulatory compliance in transfusion services.
The conference was attended by over 160 participants from Uttar Pradesh, Rajasthan, Uttarakhand, Haryana, Punjab, and Madhya Pradesh.
Technical sessions covered the National Formulary of India, the Haemovigilance Programme of India, IP Online, plasma quality, rational use of blood, and regulatory requirements.